Clinical research experts comment on the state of their fields and what developments they hope and expect to see in 2016

In an Editorial published in PLOS Medicine, editors ask an international panel of eleven expert researchers and clinicians spanning a range of specialties to answer questions on their field and what developments they hope and expect to see in 2016. Tuberculosis (TB) was one of the major topics that were raised in the panel. Philipp du Cros of Médecins Sans Frontières was asked about combating TB and points to the challenge of multidrug-resistant (MDR) TB and strategies to decrease its burden. He notes that standard MDR-TB treatment is inadequate, and says "In 2016, a more urgent scale-up of [new drugs bedaquiline and delamanid] is required... in the longer term, clinical trials are needed to define the best drug combinations enabling shorter, more effective regimens.
Source :      2016/1/5 10:18

خانه چاپ ارسال به دوستان نسخه متنی کوچک کردن متن بزرگ کردن متن دانلود خروجی پی دی اف خروجی میکروسافت ورد
0/10 (تعداد آرا 0 نفر )
Copyright © 2011 AASM. All Rights Reserved.